A cutting edge technique that allows scientists to monitor communication between cells could transform the way laboratory medical experiments are conducted. The method is likely to make laboratory studies of cancers and other human diseases, and assessment of new drugs to target them, more accurate.

The Cedars-Sinai Regenerative Medicine Institute is to provide stem cells to a five-member National Institutes of Health consortium of researchers for development of potential therapies to treat Huntington’s disease.

Advocates and experts examine progress made since the Institute of Medicine released its landmark report that called for the elimination of medical errors, or “never events,” ten years ago. Modern HealthCare interviews Helen Haskell, who founded the advocacy organization Mothers Against Medical Error, and examines progress and shortcomings: “Families are still losing loved ones to errors, Haskell explained during a recent conference hosted by Consumers Union. But the biggest difference in the past 10 years is, ‘where once there was denial, we now have tireless leaders…

Eksp Klin Gastroenterol . 2009; 97-100 The present article represents findings of quality of life index dynamics for 100 patients with gastroesophageal reflux disease under pressure of proton pump inhibitor therapy. The degree of clinical evidence was measured by Likert scale, quality of life appraisal was made on the bases of SF-36, GSRS checklists, psychoemotional component of patients’ health was analyzed with the help of the V.M

An encapsulation breakthrough by researchers at the Technion-Israel Institute of Technology may enable doctors to deliver anti-cancer drugs directly to tumors over extended periods of time, while preventing the systemic side effects of chemotherapy and other current cancer treatments.